Variables | Possible TBM (n = 28) | Definite/Probable TBM (n = 72) | P-value for comparison |
---|---|---|---|
Agea (months) | 24.5 (2–165) | 36.5 (2–180) | 0.09 |
Male (%) | 18/28 (64Â %) | 38/72 (53Â %) | 0.03 |
Fever | 28/28 (100Â %) | 71/72 (99Â %) | 0.99 |
Symptom durationa (days) | 16 (6–60) | 19.5 (6–96) | 0.172 |
Vomiting | 20/28 (71Â %) | 56/72 (78Â %) | 0.50 |
Altered sensorium | 6/28 (21Â %) | 36/72 (50Â %) | 0.01 |
Fits | 9/28 (32Â %) | 30/72 (40Â %) | 0.38 |
Neck stiffness | 17/28 (61Â %) | 58/72 (81Â %) | 0.04 |
Motor deficit | 4/25 (16Â %) | 28/60 (47Â %) | 0.01 |
Cranial nerve palsy | 9/28 (32Â %) | 18/72 (25Â %) | 0.91 |
HIV infection | 1/28 (4Â %) | 3/72 (4Â %) | 0.99 |
HBV infection | 2/28 (7Â %) | 3/72 (4Â %) | 0.86 |
Family TB history | 7/28 (25Â %) | 19/72 (26Â %) | 0.89 |
Death | 2/27 b (7Â %) | 13/69 (19Â %) c | 0.28 |
Permanent sequelae | 2/25 (8Â %) | 25/56 (45Â %) | 0.002 |
CSF WCCa (cells/uL) | 144 (4–780) | 150 (1–802) | 0.37 |
CSF Lympha (cells/uL) | 80 (40–100) | 80 % (50–100) | 0.44 |
CSF Proteina (g/L) | 0.8 (0.2–5) | 1.3 (0.1–4.8) | 0.08 |
CSF Lactatea (mmol/L) | 4.3 (1.4–8.8) | 5.6 (1.21–19.2) | 0.08 |
CSF: Blood Glucose ratioa | 0.30 (0.09–0.61) | 0.25 (0.07–0.69) | 0.51 |